Suppr超能文献

Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance.

作者信息

Terrault Norah A, Lok Anna S F, McMahon Brian J, Chang Kyong-Mi, Hwang Jessica P, Jonas Maureen M, Brown Robert S, Bzowej Natalie H, Wong John B

机构信息

Division of Gastroenterology/Hepatology University of California San Francisco San Francisco CA.

Division of Gastroenterology and Hepatology University of Michigan Ann Arbor MI.

出版信息

Clin Liver Dis (Hoboken). 2018 Aug 22;12(1):33-34. doi: 10.1002/cld.728. eCollection 2018 Jul.

Abstract
摘要

相似文献

4
A SPECIAL MEETING REVIEW EDITION: Highlights in Hepatitis C Virus From the 2017 AASLD Liver Meeting: A Review of Selected Presentations From the 2017 AASLD Liver Meeting • October 20-24, 2017 • Washington, DC• Efficacy, Safety, and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1-6 Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated Analysis• Hepatitis C Virus Reinfection and Injecting Risk Behavior Following Elbasvir/Grazoprevir Treatment in Participants on Opiate Agonist Therapy: Co-STAR Part B• Efficacy and Safety of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Treatment-Naive Patients With Chronic HCV Genotype 3: An Integrated Phase 2/3 Analysis• SOF/VEL/VOX for 12 Weeks in NS5A-Inhibitor-Experienced HCV-Infected Patients: Results of the Deferred Treatment Group in the Phase 3 POLARIS-1 Study• Adherence to Pangenotypic Glecaprevir/Pibrentasvir Treatment and SVR12 in HCV-Infected Patients: An Integrated Analysis of the Phase 2/3 Clinical Trial Program• The C-BREEZE 1 and 2 Studies: Efficacy and Safety of Ruzasvir Plus Uprifosbuvir for 12 Weeks in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 3, 4, or 6 Infection100% SVR With 8 Weeks of Ledipasvir/Sofosbuvir in HIV-Infected Men With Acute HCV Infection: Results From the SWIFT-C Trial (Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1-Infected Individuals)Chief, HepatologyUniversity Transplant CenterClinical Professor of MedicineThe University of Texas Health, San AntonioSan Antonio, Texas.一期特别会议回顾版:2017年美国肝病研究学会肝脏会议丙肝病毒研究亮点:2017年美国肝病研究学会肝脏会议部分报告回顾 • 2017年10月20 - 24日 • 华盛顿特区• 格卡瑞韦/哌柏瑞韦治疗慢性1 - 6型丙肝病毒感染合并代偿期肝硬化成人患者的疗效、安全性及药代动力学:一项综合分析• 接受阿片类激动剂治疗的参与者在接受艾尔巴韦/格拉瑞韦治疗后丙肝病毒再感染及注射风险行为:CO - STAR B部分• 格卡瑞韦/哌柏瑞韦治疗初治慢性丙肝基因3型患者8周或12周的疗效与安全性:一项2/3期综合分析• NS5A抑制剂经治的丙肝病毒感染患者使用索磷布韦/维帕他韦/伏西瑞韦治疗12周:3期POLARIS - 1研究中延迟治疗组的结果• 丙肝病毒感染患者对泛基因型格卡瑞韦/哌柏瑞韦治疗的依从性及SVR12:2/3期临床试验项目的综合分析• C - BREEZE 1和2研究:鲁扎斯韦联合乌普瑞司他韦治疗慢性丙肝病毒基因1、2、3、4或6型感染成人患者12周的疗效与安全性100% SVR率,使用来迪派韦/索磷布韦治疗8周,用于感染艾滋病毒的急性丙肝男性患者:SWIFT - C试验(不含干扰素的含索磷布韦方案治疗艾滋病毒1型感染个体的急性丙肝)结果肝病科主任大学移植中心医学临床教授德克萨斯大学健康科学中心圣安东尼奥分校德克萨斯州圣安东尼奥
Gastroenterol Hepatol (N Y). 2017 Dec;13(12 Suppl 5):1-24.
8
Management of hepatitis B: our practice and how it relates to the guidelines.乙型肝炎管理:我们的实践及其与指南的关系。
Clin Gastroenterol Hepatol. 2014 Jan;12(1):16-26. doi: 10.1016/j.cgh.2013.04.036. Epub 2013 May 6.

引用本文的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验